Mark A. Velleca serves as Executive at G1 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mark A. Velleca has executed 103 insider transactions totaling $8.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 16, 2018 involved exercising options for 7,500 shares valued at $27.9K.
Mark A. Velleca currently holds 600,000 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Velleca has been a net seller of GTHX stock. They have purchased $0 and sold $8.9M worth of shares.
Mark A. Velleca's most recent insider trade was on Jan 16, 2018, when they sold 7,500 shares at $3.72 per share.
Get notified when new Form 4 filings are submitted
| 7,500 |
| $3.72 |
| Discretionary |
| Dec 18, 2017 | GTHX | $150.1K | Sale | 7,500 | $20.01 | Discretionary |